{
    "hands_on_practices": [
        {
            "introduction": "Effective management of complex pancreatic fluid collections demands more than memorizing guidelines; it requires the ability to synthesize multiple clinical variables into a coherent treatment plan. This first practice challenges you to construct a decision algorithm from foundational principles, integrating anatomical location, ductal integrity, and debris burden to select the optimal initial drainage modality. By applying this systematic approach, you will develop the strategic thinking necessary to tailor interventions for walled-off necrosis, a critical skill for the modern surgeon. ",
            "id": "4653039",
            "problem": "A 46-year-old individual presents 6 weeks after an episode of severe necrotizing pancreatitis with persistent abdominal pain, fever of $38.5\\,^{\\circ}\\mathrm{C}$, and leukocytosis of $15{,}000/\\mathrm{mm}^3$. Contrast-enhanced computed tomography shows a well-circumscribed, encapsulated collection in the lesser sac measuring $12 \\times 10\\,\\mathrm{cm}$ with heterogeneous attenuation and an estimated solid debris fraction of $s = 0.60$ (i.e., $60\\%$ nonliquefied necrotic material consistent with walled-off necrosis). The shortest distance from the collection capsule to the posterior gastric wall is $d = 4\\,\\mathrm{mm}$. Endoscopic Retrograde Cholangiopancreatography (ERCP) demonstrates a main pancreatic duct disruption at the neck with no traversable continuity to the upstream duct (disconnected pancreatic duct syndrome). Magnetic resonance cholangiopancreatography suggests no direct ductal communication between the collection and the downstream pancreatic duct, so let the ductal communication indicator be $c = 0$. Blood cultures are positive, so we set the infection indicator $i = 1$. There are no additional remote collections, and there is no organ failure. The gastrointestinal wall overlying the collection is not ulcerated, and the capsule appears mature.\n\nUsing the Revised Atlanta Classification and core principles of pancreatic fluid collection management, derive a decision algorithm that maps the triplet $(d, c, s)$ together with timing $t$ and infection $i$ into an initial drainage modality chosen among the following: endoscopic ultrasound-guided transmural drainage, endoscopic transpapillary drainage, percutaneous catheter drainage, or surgical drainage. The derivation must start from the following foundational bases:\n\n- Definitions: A pancreatic pseudocyst is a mature encapsulated peripancreatic fluid collection with negligible solid debris ($s \\approx 0$), typically forming after $t \\ge 4$ weeks; walled-off necrosis is a mature encapsulated collection with a mixture of liquid and solid necrotic debris ($s > 0$), also typically after $t \\ge 4$ weeks.\n- Well-tested clinical facts: Symptomatic or infected mature collections warrant intervention; Endoscopic Ultrasound (EUS)-guided transmural drainage is feasible and preferred when the collection abuts the gastric or duodenal lumen ($d$ small) due to a shorter transluminal route; collections with substantial solid debris ($s$ large) require a conduit that can accommodate debridement; transpapillary drainage via ERCP is effective primarily when a pseudocyst communicates with the main pancreatic duct ($c = 1$) and the transmural window is poor; percutaneous drainage is useful for infected collections not amenable to endoscopic access but risks an external pancreatic fistula, especially with disconnected duct; surgical drainage or necrosectomy is generally reserved for failure of minimally invasive approaches or inaccessible anatomy.\n\nConstruct decision rules using inequalities and logical conditions on $(d, c, s, t, i)$ without invoking shortcut guidelines, then apply your derived algorithm to this patient to select the single best initial modality from the options below. Choose the one option that most precisely reflects the algorithm’s output for the described state.\n\nOptions:\nA. EUS-guided transmural drainage using a lumen-apposing metal stent with planned direct endoscopic necrosectomy sessions.\nB. ERCP-guided transpapillary pancreatic duct stenting alone to drain the collection via ductal communication.\nC. Image-guided percutaneous catheter drainage as the primary intervention.\nD. Upfront open surgical cystgastrostomy and necrosectomy.\nE. Combined initial ERCP with transpapillary stenting followed by delayed observation without transmural drainage.",
            "solution": "The problem statement will be validated by first extracting all givens and then assessing them against criteria for scientific soundness, completeness, and logical consistency.\n\n### Step 1: Extract Givens\n\nThe following data and principles are provided in the problem statement:\n\n**Patient Clinical Data:**\n*   Age: 46 years\n*   Time since pancreatitis ($t$): 6 weeks\n*   Symptoms: Persistent abdominal pain, fever\n*   Temperature: $38.5\\,^{\\circ}\\mathrm{C}$\n*   Leukocyte count: $15{,}000/\\mathrm{mm}^3$\n*   Imaging modality: Contrast-enhanced computed tomography (CT)\n*   Collection location: Lesser sac\n*   Collection size: $12 \\times 10\\,\\mathrm{cm}$\n*   Collection characteristics: Well-circumscribed, encapsulated, heterogeneous attenuation\n*   Solid debris fraction ($s$): $s = 0.60$\n*   Inferred diagnosis based on $s > 0$ and $t \\ge 4$ weeks: Walled-off necrosis (WON)\n*   Distance from collection to posterior gastric wall ($d$): $d = 4\\,\\mathrm{mm}$\n*   Pancreatic duct integrity (from ERCP): Main pancreatic duct disruption at the neck (disconnected pancreatic duct syndrome)\n*   Ductal communication indicator ($c$): $c = 0$ (no communication between collection and downstream duct)\n*   Infection indicator ($i$): $i = 1$ (positive blood cultures)\n*   Additional findings: No other collections, no organ failure, non-ulcerated overlying GI wall, mature capsule\n\n**Foundational Bases for Algorithm:**\n*   **Definition of Pseudocyst:** Mature ($t \\ge 4$ weeks) encapsulated collection with $s \\approx 0$.\n*   **Definition of Walled-Off Necrosis (WON):** Mature ($t \\ge 4$ weeks) encapsulated collection with $s > 0$.\n*   **Principle 1:** Symptomatic or infected ($i=1$) mature ($t \\ge 4$ weeks) collections require intervention.\n*   **Principle 2:** Endoscopic ultrasound (EUS)-guided transmural drainage is preferred when $d$ is small (collection abuts GI lumen).\n*   **Principle 3:** Collections with large $s$ require a conduit that accommodates debridement.\n*   **Principle 4:** Endoscopic retrograde cholangiopancreatography (ERCP)-guided transpapillary drainage is effective for pseudocysts ($s \\approx 0$) with ductal communication ($c=1$) and poor transmural access.\n*   **Principle 5:** Percutaneous catheter drainage (PCD) is useful for infected collections ($i=1$) not amenable to endoscopic access but has a high risk of external pancreatic fistula with a disconnected duct.\n*   **Principle 6:** Surgical drainage is reserved for failure of minimally invasive approaches or inaccessible anatomy.\n\n### Derivation of Decision Algorithm and Application\n\nWe will construct a decision algorithm based on the provided principles to map the state $(d, c, s, t, i)$ to an initial drainage modality.\n\n1.  **Determine the Need for Intervention:**\n    According to Principle 1, intervention is warranted for symptomatic or infected mature collections.\n    *   The collection is mature: $t = 6 \\text{ weeks} \\ge 4 \\text{ weeks}$.\n    *   The patient is symptomatic (pain, fever) and the collection is infected ($i=1$ based on positive blood cultures).\n    *   **Conclusion:** Intervention is mandatory. Observation is not an option.\n\n2.  **Evaluate Drainage Modalities:**\n\n    a.  **ERCP-guided Transpapillary Drainage:**\n        *   According to Principle 4, this modality is effective for pseudocysts ($s \\approx 0$) that communicate with the pancreatic duct ($c=1$).\n        *   In this case, the collection is WON, not a pseudocyst, with a substantial solid fraction $s=0.60$. Furthermore, there is no ductal communication, $c=0$.\n        *   **Conclusion:** ERCP-guided transpapillary drainage is contraindicated. This rules out any options centered on this approach.\n\n    b.  **Surgical Drainage (Upfront):**\n        *   According to Principle 6, surgery is generally reserved for the failure of minimally invasive approaches.\n        *   Since this is the *initial* intervention, and minimally invasive options have not been attempted, upfront surgery violates this principle. It is the most invasive option with the highest associated morbidity.\n        *   **Conclusion:** Upfront surgical drainage is not the preferred initial modality.\n\n    c.  **Percutaneous Catheter Drainage (PCD) vs. EUS-guided Transmural Drainage:**\n        *   We must choose between the two remaining minimally invasive options based on the patient's specific parameters.\n        *   **Anatomical Accessibility:** Principle 2 states that EUS-guided transmural drainage is preferred for collections abutting the GI lumen ($d$ is small). The patient's collection is $d=4\\,\\mathrm{mm}$ from the gastric wall, which is an ideal distance for a safe and effective EUS-guided approach. This strongly favors EUS over other methods.\n        *   **Nature of Collection Contents:** Principle 3 states that collections with substantial solid debris ($s>0$) require a conduit that can accommodate debridement. The patient has $s=0.60$, indicating a large volume of necrotic solid material that must be removed. Standard PCD catheters or small endoscopic stents are insufficient for this task. Effective drainage and debridement require a large-diameter access port. EUS-guided placement of a large-bore, lumen-apposing metal stent (LAMS) creates a wide cystogastrostomy tract. This tract is large enough to allow a gastroscope to pass directly into the necrotic cavity for subsequent sessions of direct endoscopic necrosectomy (DEN).\n        *   **Ductal Anatomy and Fistula Risk:** Principle 5 notes that PCD carries a risk of a pancreatocutaneous fistula, especially with a disconnected duct. This patient has a disconnected pancreatic duct. An external percutaneous drain would almost certainly result in a persistent, high-output fistula, a significant complication. In contrast, EUS-guided drainage creates a permanent *internal* fistula (a cystogastrostomy), which is the definitive treatment for a disconnected duct that continues to leak into a collection.\n        *   **Synthesis:** EUS-guided drainage is anatomically ideal ($d=4\\,\\mathrm{mm}$), provides the necessary large-bore access for necrosectomy (via LAMS) required by the high solid fraction ($s=0.60$), and avoids the high risk of a pancreatocutaneous fistula associated with PCD in the setting of a disconnected duct.\n\n3.  **Final Algorithm Output:**\n    For the patient's state vector $(d=4\\,\\mathrm{mm}, c=0, s=0.60, t=6\\,\\text{weeks}, i=1)$, the derived algorithm yields the following:\n    *   Intervention is required.\n    *   An endoscopic approach is preferred due to the favorable anatomy ($d=4\\,\\mathrm{mm}$).\n    *   A transmural approach is necessary.\n    *   This approach must accommodate the removal of significant solid debris ($s=0.60$), which requires a large-bore stent (LAMS) to facilitate direct endoscopic necrosectomy.\n    *   This approach definitively manages the underlying disconnected duct syndrome by creating a permanent internal drainage pathway.\n    *   **The optimal initial modality is EUS-guided transmural drainage with LAMS placement, followed by planned direct endoscopic necrosectomy.**\n\n### Evaluation of Options\n\n*   **A. EUS-guided transmural drainage using a lumen-apposing metal stent with planned direct endoscopic necrosectomy sessions.**\n    This option precisely matches the conclusion derived from the application of the foundational principles. It addresses the infection, the anatomical accessibility, the need for debridement of necrotic solids, and the underlying disconnected duct in the most effective and least invasive manner.\n    **Verdict: Correct.**\n\n*   **B. ERCP-guided transpapillary pancreatic duct stenting alone to drain the collection via ductal communication.**\n    This is incorrect. The collection does not communicate with the duct ($c=0$), and it contains a high fraction of solids ($s=0.60$), making it unsuitable for transpapillary drainage.\n    **Verdict: Incorrect.**\n\n*   **C. Image-guided percutaneous catheter drainage as the primary intervention.**\n    This is an inferior choice. While it can drain infected fluid, it is not the preferred method when EUS access is excellent ($d=4\\,\\mathrm{mm}$). Most importantly, it carries a very high risk of creating a chronic pancreatocutaneous fistula in this patient with a disconnected pancreatic duct, whereas the EUS approach provides a definitive internal drainage solution.\n    **Verdict: Incorrect.**\n\n*   **D. Upfront open surgical cystgastrostomy and necrosectomy.**\n    This is incorrect. It violates the modern \"step-up\" approach (Principle 6), where highly invasive surgery is reserved for the failure of minimally invasive techniques. The morbidity of upfront surgery is substantially higher than the EUS-guided approach.\n    **Verdict: Incorrect.**\n\n*   **E. Combined initial ERCP with transpapillary stenting followed by delayed observation without transmural drainage.**\n    This option is fundamentally flawed. The ERCP component is futile (as per analysis of option B). The \"delayed observation\" component is dangerous and contraindicated for a patient with a large, symptomatic, infected collection.\n    **Verdict: Incorrect.**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Once a transluminal drainage approach is chosen for walled-off necrosis (WON), the success of the intervention hinges on technical execution, starting with the selection of appropriate hardware. This exercise moves from high-level strategy to a crucial tactical decision: choosing the correct stent diameter. You will apply principles of fluid dynamics and instrument compatibility to justify why a larger stent is necessary for effective direct endoscopic necrosectomy, demonstrating how a fundamental equipment choice directly impacts procedural feasibility and patient outcomes. ",
            "id": "4653101",
            "problem": "A 54-year-old patient presents 4 weeks after severe necrotizing pancreatitis with fever, abdominal pain, and early organ dysfunction. Contrast-enhanced computed tomography shows a mature encapsulated collection in the lesser sac measuring a maximal dimension of $15 \\, \\mathrm{cm}$, with heterogeneous attenuation and an estimated solid necrotic fraction exceeding $50\\%$, consistent with walled-off necrosis (WON). Endoscopic ultrasound-guided transluminal drainage with a Lumen-Apposing Metal Stent (LAMS) is planned, and direct endoscopic necrosectomy (DEN) is anticipated due to the thick, adherent debris. The team must choose between a $10 \\, \\mathrm{mm}$ and a $15 \\, \\mathrm{mm}$ LAMS.\n\nStarting from first principles relevant to general surgery of pancreatic collections, use the following fundamental bases to reason which choice is most appropriate:\n\n- By definition, a pancreatic pseudocyst is an encapsulated fluid collection with negligible solid debris, whereas WON is an encapsulated collection containing variable amounts of solid necrosis. Collections with substantial solid content frequently require mechanical debridement via DEN rather than passive drainage alone.\n- Safe passage of a therapeutic gastroscope for DEN requires that the stent inner diameter exceeds the outer diameter of the scope with a practical margin to accommodate tissue apposition, stent flare, and dynamic deformation. A typical therapeutic gastroscope has an outer diameter of approximately $9.8 \\, \\mathrm{mm}$.\n- For the liquid fraction of the collection, the instantaneous volume flow through a cylindrical conduit under laminar conditions is governed by the Hagen–Poiseuille relationship, $$Q \\propto r^4,$$ and cross-sectional area is $$A = \\pi r^2,$$ where $r$ is the radius of the conduit. Even acknowledging that necrotic contents are non-Newtonian and include solids, larger luminal diameter reduces the probability of clogging and increases the margin for instrument passage and repeated debridement.\n\nWhich option provides the most scientifically sound justification for selecting the $15 \\, \\mathrm{mm}$ LAMS rather than the $10 \\, \\mathrm{mm}$ LAMS in this patient?\n\nA. Choose the $15 \\, \\mathrm{mm}$ LAMS because its inner diameter comfortably exceeds the approximately $9.8 \\, \\mathrm{mm}$ outer diameter of a therapeutic gastroscope, enabling repeated DEN without stent-induced compression; the cross-sectional area and laminar flow capacity scale as $A \\propto r^2$ and $Q \\propto r^4$, making a $15 \\, \\mathrm{mm}$ lumen provide roughly $\\left(\\frac{15}{10}\\right)^2$ times the area and $\\left(\\frac{15}{10}\\right)^4$ times the flow capacity for the liquid fraction compared with a $10 \\, \\mathrm{mm}$ stent, thereby mitigating occlusion by viscous debris.\n\nB. Choose the $10 \\, \\mathrm{mm}$ LAMS to minimize bleeding and buried stent risk; smaller diameter stents cause less tissue trauma and are equally effective for thick debris because suction alone evacuates solids.\n\nC. Prefer two double-pigtail plastic stents over LAMS because plastic stents resist occlusion better in necrotic collections and their narrow lumens allow DEN accessories to pass while avoiding endoscope passage through the stent.\n\nD. Avoid LAMS entirely and use percutaneous catheter drainage because large WON with thick debris is best managed with percutaneous drains alone, which are superior to endoscopic approaches for evacuating solids.\n\nE. Use the $15 \\, \\mathrm{mm}$ LAMS only when the collection exceeds $20 \\, \\mathrm{cm}$; at $15 \\, \\mathrm{cm}$ maximal dimension, a $10 \\, \\mathrm{mm}$ LAMS provides adequate clearance for DEN in most cases.",
            "solution": "The problem asks to justify the selection of a $15 \\, \\mathrm{mm}$ Lumen-Apposing Metal Stent (LAMS) over a $10 \\, \\mathrm{mm}$ LAMS for a patient with large, complex walled-off necrosis (WON) requiring direct endoscopic necrosectomy (DEN). The justification must be derived from the provided first principles.\n\n1.  **Mechanical Requirement for Direct Endoscopic Necrosectomy (DEN):** The primary driver for stent selection is the procedural need for DEN, as stated in Principle 1 for collections with substantial solid content. Principle 2 establishes the critical mechanical constraint: a therapeutic gastroscope, with an outer diameter of approximately $9.8 \\, \\mathrm{mm}$, must pass through the stent.\n    *   A $10 \\, \\mathrm{mm}$ LAMS offers a nominal diameter that is only $0.2 \\, \\mathrm{mm}$ wider than the endoscope. This leaves a radial clearance of only $0.1 \\, \\mathrm{mm}$, which is insufficient for safe and practical passage. It fails to provide the \"practical margin\" required to accommodate tissue apposition and dynamic forces during the procedure.\n    *   A $15 \\, \\mathrm{mm}$ LAMS, however, provides a nominal diameter $5.2 \\, \\mathrm{mm}$ wider than the scope, offering a comfortable margin that enables safe, repeated intubation of the necrotic cavity for effective debridement.\n\n2.  **Fluid and Debris Dynamics:** The patient's collection has a solid fraction exceeding $50\\%$. Principle 3 relates stent diameter to drainage efficiency and risk of clogging.\n    *   **Cross-Sectional Area:** The area available for drainage is proportional to the radius squared ($A \\propto r^2$). The ratio of areas for a $15 \\, \\mathrm{mm}$ vs. a $10 \\, \\mathrm{mm}$ stent is $\\left(\\frac{15}{10}\\right)^2 = 2.25$. The larger stent offers more than double the area, significantly reducing the risk of occlusion by solid debris.\n    *   **Flow Rate:** For the liquid fraction, the flow rate is proportional to the radius to the fourth power ($Q \\propto r^4$). The ratio of flow rates is $\\left(\\frac{15}{10}\\right)^4 \\approx 5.06$. The larger stent provides over five times the potential flow rate, drastically improving passive drainage of viscous fluid.\n\n**Conclusion:** The $15 \\, \\mathrm{mm}$ LAMS is superior for two compelling reasons: it is a mechanical necessity for performing DEN with a standard therapeutic gastroscope, and its larger dimensions provide superior drainage and lower risk of occlusion, both critical for managing a large WON with significant solid debris.\n\n**Evaluation of Options:**\n\n*   **A:** This option correctly identifies the need for sufficient clearance for the gastroscope and accurately applies the scaling laws for cross-sectional area and flow rate ($A \\propto r^2$ and $Q \\propto r^4$). Its reasoning is a direct and complete application of all the provided principles. **This is the correct answer.**\n*   **B:** This option incorrectly claims a $10 \\, \\mathrm{mm}$ LAMS is \"equally effective\" and that suction alone is sufficient, contradicting the need for DEN in collections with thick, adherent debris.\n*   **C:** This option incorrectly suggests that plastic stents are superior for necrotic collections; they are, in fact, more prone to clogging. It also misunderstands DEN, which requires passing the endoscope itself into the cavity.\n*   **D:** This option evades the question by arguing for a different modality (percutaneous drainage) rather than comparing the stent sizes as requested.\n*   **E:** This option introduces an arbitrary size threshold ($20 \\, \\mathrm{cm}$) not based on the principles and incorrectly states that a $10 \\, \\mathrm{mm}$ LAMS is adequate for DEN, which is mechanically false.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "A hallmark of surgical expertise is the ability to adapt when confronted with unexpected intraprocedural findings. This final practice simulates a critical scenario where real-time endoscopic ultrasound data challenge a preoperative diagnosis, raising the suspicion of a cystic neoplasm instead of an inflammatory collection. Your task is to apply core principles of surgical oncology to navigate this diagnostic uncertainty, prioritizing the avoidance of tumor seeding and ensuring the patient is directed toward the correct oncologic pathway. ",
            "id": "4653088",
            "problem": "A 56-year-old person with a history of moderately severe acute necrotizing pancreatitis 8 weeks ago presents with early satiety and postprandial pain. Cross-sectional imaging shows a $5$ to $6 \\, \\mathrm{cm}$ encapsulated cystic collection abutting the posterior wall of the stomach. The patient is scheduled for endoscopic drainage. During real-time Endoscopic Ultrasound (EUS) immediately before planned Lumen-Apposing Metal Stent (LAMS) placement, the endoscopist notes the following: a thick, enhancing wall with internal septations, a $1 \\, \\mathrm{cm}$ mural nodule, absence of echogenic solid necrotic debris, and upstream main pancreatic duct dilation to $6 \\, \\mathrm{mm}$ without surrounding inflammatory changes. These findings raise concern for a cystic neoplasm rather than a pancreatic pseudocyst or walled-off necrosis.\n\nStarting from core definitions and well-tested facts, reason through how these EUS features distinguish a pancreatic pseudocyst or walled-off necrosis from a cystic neoplasm, and apply foundational surgical oncology principles (maintaining intact tumor planes, avoiding contamination and seeding, and pursuing staging before definitive therapy) to determine the best next step that avoids oncologic compromise. Which of the following is the most appropriate course of action?\n\nA. Proceed with transgastric drainage using LAMS to relieve symptoms now, and send cyst fluid for cytology and Carcinoembryonic Antigen (CEA) testing.\n\nB. Abort drainage; obtain pancreatic protocol Computed Tomography (CT) and Magnetic Resonance Imaging with Magnetic Resonance Cholangiopancreatography (MRI/MRCP), then refer for EUS-based staging and oncologic surgical evaluation; avoid any transmural or percutaneous drainage pathways.\n\nC. Place a percutaneous drain under Interventional Radiology (IR) guidance to temporize symptoms, and plan elective oncologic resection in 6 weeks.\n\nD. Perform a surgical cystojejunostomy now to palliate obstructive symptoms, and plan resection after inflammation subsides.\n\nE. Perform a transgastric needle biopsy of the mural nodule and place a small-caliber plastic stent for limited drainage until diagnosis is clarified.\n\nChoose the single best option.",
            "solution": "Begin by distinguishing entities based on core definitions and well-tested facts in pancreatic disease and surgical oncology:\n\n1. Definition of a pancreatic pseudocyst: A pancreatic pseudocyst is an encapsulated collection of enzyme-rich fluid that develops typically $\\ge 4$ weeks after acute pancreatitis, characterized by a mature fibrous wall and the absence of an epithelial lining. It generally contains homogeneous fluid, often with high amylase, and lacks mural nodules or thick enhancing walls.\n\n2. Definition of walled-off necrosis: Walled-off necrosis is a late ($\\ge 4$ weeks) sequela of necrotizing pancreatitis characterized by an encapsulated collection containing both liquid and solid necrotic debris. On EUS or Computed Tomography (CT), it exhibits heterogeneous echogenic or density content with visible solid components and often debris layering.\n\n3. Features suggestive of cystic neoplasm: Mucinous cystic lesions (e.g., mucinous cystic neoplasm and intraductal papillary mucinous neoplasm) often show septations, mural nodules, thick enhancing walls, and may be associated with dilation of the main pancreatic duct. Cyst fluid analysis typically reveals elevated Carcinoembryonic Antigen (CEA), for example $> 192 \\, \\mathrm{ng/mL}$ supporting mucinous etiology, and amylase may be variable depending on ductal communication. The presence of mural nodules and a dilated upstream duct are high-risk features for malignancy.\n\n4. Surgical oncology principles: Foundational oncologic tenets include maintaining intact tumor planes, avoiding iatrogenic violation of a tumor capsule, preventing contamination of adjacent luminal organs and peritoneal cavity, and performing appropriate staging prior to definitive resection. Creating nonanatomic tracts (e.g., cystogastrostomy or percutaneous drainage) through a lesion that may be neoplastic risks tumor seeding along the tract, intraluminal contamination, and compromises subsequent en bloc resection and margin control.\n\nApply these principles to the scenario:\n\n- The EUS findings in this case—thick enhancing wall, internal septations, a $1 \\, \\mathrm{cm}$ mural nodule, absent necrotic debris, and dilated main duct to $6 \\, \\mathrm{mm}$—are classic for a cystic neoplasm rather than a pseudocyst or walled-off necrosis. A pseudocyst would typically show homogeneous fluid without mural nodules and often in the context of a clearly inflamed pancreas; walled-off necrosis would show echogenic solid debris.\n\n- Thus, any plan that creates a cyst-enteric or cyst-cutaneous tract through the lesion (transgastric Lumen-Apposing Metal Stent, surgical cystojejunostomy, or percutaneous drainage) risks violating oncologic planes, seeding tumor cells into the gastrointestinal lumen or abdominal wall, and complicating subsequent curative resection.\n\n- The correct immediate action is to abort drainage, obtain high-quality staging with pancreatic protocol CT and Magnetic Resonance Imaging with Magnetic Resonance Cholangiopancreatography (MRI/MRCP), and refer for Endoscopic Ultrasound (EUS) evaluation in a diagnostic context and surgical oncology consultation. Endoscopic Ultrasound with Fine-Needle Aspiration (FNA) of cyst fluid and/or mural nodules may be considered selectively to refine diagnosis, but when high-risk features are present and the lesion is clearly resectable, proceeding directly to oncologic resection without creating nonanatomic drainage tracts is appropriate. Crucially, avoidance of any transmural or percutaneous drainage pathways prevents oncologic compromise.\n\nOption-by-option analysis:\n\nA. Proceeding with Lumen-Apposing Metal Stent placement establishes a cystogastrostomy tract through a suspected neoplasm, violating oncologic principles by risking tumor seeding into the stomach and compromising margin integrity for future resection. Although cyst fluid analysis can aid diagnosis, the act of drainage in this context is the problem. Verdict — Incorrect.\n\nB. Aborting drainage, attaining comprehensive staging with pancreatic protocol CT and MRI/MRCP, and referring for oncologic evaluation aligns with the foundational principles of maintaining intact tumor planes and avoiding contamination. It explicitly avoids transmural or percutaneous drainage, preserving the possibility of en bloc resection and minimizing seeding risk. EUS in a diagnostic framework may be used judiciously; the key is no drainage or tract creation. Verdict — Correct.\n\nC. Percutaneous drainage creates a cutaneous tract through a suspected neoplasm, risking tumor seeding along the tract and compromising future resection. Temporization by drainage in this context is contraindicated. Verdict — Incorrect.\n\nD. A surgical cystojejunostomy forms a permanent cyst-enteric anastomosis through a suspected neoplasm, violating oncologic planes, risking intraluminal tumor spread, and complicating subsequent en bloc resection. Verdict — Incorrect.\n\nE. Transgastric biopsy combined with placement of a stent creates a transmural tract and establishes drainage, with similar concerns of seeding and oncologic compromise. Even without a stent, puncturing a suspected malignant cyst to create communication is risky; adding a stent compounds the problem. Verdict — Incorrect.\n\nTherefore, the single best choice that avoids oncologic compromise is to abort drainage and proceed with proper staging and oncologic referral while avoiding any tract creation.",
            "answer": "$$\\boxed{B}$$"
        }
    ]
}